FDA inspection

Celerion, Inc.: FDA inspection ending Mar 13, 2010

FDA inspection 652189 · Voluntary Action Indicated (VAI) · Fehraltorf

Key facts

Inspection ID	652189
Firm	Celerion, Inc.
FEI number	3008184599
Address	Allmendstrasse 32
City	Fehraltorf
Fiscal year	2010
Inspection end date	Mar 13, 2010
Classification	Voluntary Action Indicated (VAI)
Project area	Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs
Product type	Drugs

At a glance

None Citations
1–9 Posted citations
No Warning letter followed
Yes Form FDA 483 issued
Yes Establishment inspection report (EIR) exists
1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections